Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Infliximab for Grade III or IV Immune Checkpoint Inhibitor Nephritis Clinical and Translational Evidence.
Journal: Kidney international reports
Published: September 16, 2025
Nephrotoxicity of conventional chemotherapeutics: part II-non-platinum agents and miscellaneous nephrotoxic drugs.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: August 06, 2025
Nephrotoxicity of conventional chemotherapeutics: part 1-platinum compounds and antimetabolite agents.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: August 05, 2025
Rituximab for the treatment of immune checkpoint inhibitor-induced glomerulonephritis.
Journal: Clinical kidney journal
Published: July 18, 2025
Potential Benefit of Sodium-Glucose Cotransporter 2-Inhibitors in Cisplatin-Associated Nephrotoxicity Among Patients With Cancer Having Diabetes Mellitus.
Journal: Kidney international reports
Published: June 26, 2025
Nilotinib-Induced Unilateral Renal Artery Stenosis: A Complication Prompting Treatment-Free Remission in Chronic Myeloid Leukemia.
Journal: Case reports in oncological medicine
Published: June 05, 2025
Correcting hyponatraemia is associated with improved survival in hyponatraemic metastatic cancer patients.
Journal: Clinical kidney journal
Published: October 28, 2024
Infliximab for Treatment of Immune Adverse Events and Its Impact on Tumor Response.
Journal: Cancers
Published: September 17, 2023
Real-world analysis of safety and efficacy of CAR T-cell therapy in lymphoma patients with decreased kidney function.
Journal: British journal of haematology
Published: June 11, 2023
Last Updated: 09/26/2026